Controlled release implant dosage forms for cardiac arrhythmias: Review and perspectives

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 3, Issue 3, 1996, Pages 137-142

  Levy, Robert J ^a,b,c   Labhasetwar, Vinod ^a,b   Strickberger, S Adam ^a   Underwood, Thomas ^a   Davis, James ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Box 0576 ^*  (United States)

Author keywords

drug delivery; local therapy; polymer implants

Indexed keywords

ANTIARRHYTHMIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CYCLOSPORIN A; DEXAMETHASONE; IBUTILIDE; LIDOCAINE; POLYMER; PROPRANOLOL; SOTALOL; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL MODEL; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG RELEASE; HEART ARRHYTHMIA; HEART ATRIUM FLUTTER; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANT; INTRACARDIAC DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; IONTOPHORESIS; KINETICS; METHODOLOGY; NONHUMAN; PHARMACEUTICS; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

EID: 0029807482     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.3109/10717549609029442     Document Type: Conference Paper

References (36)

1. Labhasetwar, V., and Levy, R. J. (1995) Novel delivery of antiarrhythmic agents. Clin. Pharmacokinet. 29, 1-5.
2. Chakko, S., and Kessler, K. M. (1995) Recognition and management of cardiac arrhythmias. Curr. Probl. Cardiol. 20, 53-117.
3. Sintov, A., Scott, W., Dick, M., and Levy, R. J. (1988) Cardiac controlled release for arrhythmia therapy: lidocaine-polyurethane matrix studies. J. Com. Rel. 8, 157-165.
4. Langer, R. (1990) New methods of drug delivery. Science 249, 1527-1533.
5. Labhasetwar, V., and Levy, R. J. (1992) Polymer systems for cardiovascular drug delivery. Polym. News 17, 336-342.
6. Bolling, S. F., Lin, H., Annesley, T. M., Boyd, J. A., Gallagher, K. P., and Levy, R. J. (1991) Local cyclosporine immunotherapy of heart transplants in rats enhances survival. J. Heart Lung Transplant. 10, 577-583.
7. Mond, H. G., Stokes, K. B. (1992) The electrode-tissue interface: the revolutionary role of steroid elution. Pacing Clin. Electrophysiol. 15, 95-107.
8. Karpawich, P. P., Stokes, K. B., Proctor, K., Schallhorn, R., McVenes, R., and Factkor, M. (1994) Improved epimyocardial pacing: initial experience with a new bipolar, steroid-eluting, high impedance lead design. Pacing Clin. Electrophysiol. 2032-2037.
9. Levy, R. J., Wolfrum, J., Schoen, F. J., Hawley, M. A., Lund, S. A., and Langer, R. (1985) Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate. Science 228, 190-192.
10. 3: controlled release polymers for preventing calcification of bioprosthetic aortic wall. J. Cont. Rel. 34, 97-108.
11. Okada, T., Bark, D. H., and Mayberg, M. R. (1989) Localized release of perivascular heparin inhibits intimal proliferation after endothelial injury without systemic anticoagulation. Neurosurgery 25, 892-898.
12. Edelman, E. R., Adams, D. H., and Karnovsky, M. J. (1990) Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury. Proc. Natl. Acad. Sci. USA 87, 3773-3777.
13. Villa, A. E., Guzman, L. A., Chen, W., Golomb, G., Levy, R. J., and Topol, E. J. (1994) Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J. Clin. Invest. 93, 1243-1249.
14. Villa, A. E., Guzman, L. A., Poptic, E. J., Labhasetwar, V., D'Souza, S., Farrell, C. L., Plow, E. F., Levy, R. J., DiCorleto, P., and Topol, E. J. (1995) The effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury. Circ. Res. 76, 505-513.
15. Buchanan, L. V., Kabell, G., Brunden, M. N., and Gibson, J. K. (1993) Comparative assessment of ibutilide, D-sotalol, clofilium, E-4031, and UK-68,798 in a rabbit model of proarrhythmia. J. Cardiovasc. Pharmacol. 22, 540-549.
16. Sintov, A., Scott, W. A., Gallagher, K. P., and Levy, R. J. (1990) Conversion of ouabain induced ventricular tachycardia in dogs with epicardial lidocaine: pharmacodynamics and function. Pharm. Res. 7, 28-33.
17. Siden, R., Flowers, W. E., and Levy, R. J. (1992) Epicardial propranolol administration for ventricular arrhythmias in dogs: matrix formulation and characterization. Biomaterials 13, 764-770.
18. Siden, R., Kadish, A., Flowers, W., Kutas, L., Bieneman, B. K., DePietro, J., Jenkins, J. M., Gallagher, K. P., and Levy, R. J. (1992) Epicardial controlled release verapamil prevents ventricular tachycardia episodes induced by acute ischemia in a canine model. J. Cardiovasc. Pharmacol. 19, 798-809.
19. Labhasetwar, V., Kadish, A., Underwood, T., Sirinek, M., and Levy, R. J. (1992) The efficacy of controlled release d-sotalol-polyurethane epicardial implants for ventricular arrhythmias due to acute ischemia in dogs. J. Cont. Rel. 23, 75-86.
20. Labhasetwar, V., Underwood, T., Gallagher, M., Murphy, G., Langberg, J., and Levy, R. J. (1994) Sotalol controlled release systems for arrhythmias: in vitro characterization, in vivo drug disposition, and electrophysiologic effects. J. Pharm. Sci. 83, 156-164.
21. Apuri, B., Labhasetwar, V., Brooks, R., Robinson, N., Goldberger, J., Levy, R., and Kadish, A. (1994) Effects of epicardial sotalol in a canine myocardial infarct model. American College of Cardiology 43rd Annual Scientific Session, Atlanta, GA.
22. Strickberger, S. A., Labhasetwar, V., Davis, J., Underwood, T., and Levy, R. J. (1996) Prevention of atrial flutter with epicardial artilide. American College of Cardiology 45th Annual Scientific Session.
23. Strickberger, S. A., Labhasetwar, V., Davis, J., Underwood, T., and Levy, R. J. (1996) Reduced defibrillation thresholds with endocardial administration of artilide. American College of Cardiology 45th Annual Scientific Session, 1996.
24. Labhasetwar, V., Underwood, T., Heil, R. W., Jr., Gallagher, M., Langberg, J., and Levy, R. J. (1994) Epicardial administration of ibutilide from Polyurethane matrices: effects on defibrillation threshold and electrophysiologic parameters. J. Cardiovasc. Pharm. 24, 826-840.
25. Edelman, E. R., Kost, J., Bobeck, H., and Langer, R. (1985) Regulation of drug release from polymer matrices by oscillating magnetic fields. J. Biomed. Mater. Res. 19, 67-83.
26. Edelman, E. R., Brown, L., Taylor, J., and Langer, R. (1987) In vitro and in vivo kinetics of regulated drug release from polymer matrices by oscillating magnetic fields. J. Biomed. Mater. Res. 21, 339-353.
27. Kost, J., Leong, K., and Langer, R. (1989) Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc. Natl. Acad. Sci. USA 86, 7663-7666.
28. Machluf, M., and Kost, J. (1993) Ultrasonically enhanced transdermal drug delivery: experimental approaches to elucidate the mechanism. Biomater. Sci. Polym. Ed. 5, 147-156.
29. Collins, S. M., and Arzbaecher, R. C. (1979) Feedback control in the management of cardiac arrhythmias. ISA Trans. 18, 95-100.
30. Polikaitis, A., and Arzbaecher, R. (1994) Sensitivity and specificity of a dual-chamber arrhythmia recognition algorithm for implantable devices. J. Electrocardiol. 27 (suppl.), 78-83.
31. Barrett, D. H., Davidson, P. C., Steed, L. J., Abel, G. G., Loman, K. E., and Saudek, C. D. (1995) Evaluation of the psychosocial impact of the MiniMed variable-rate implantable insulin pump. South. Med. J. 88, 1226-1230.
32. Schwendeman, S. P., Amidon, G. L., Meyerhoff, M. E., and Levy, R. J. (1992) Modulated drug release using iontophoresis through heterogeneous cation-exchange membranes: membrane preparation and influence of resin cross-linkage. Macromolecules 25, 2531-2540.
33. Labhasetwar, V., Underwood, T., Schwendeman, S. P., and Levy, R. J. (1995) Iontophoresis for modulation of cardiac drug delivery. Proc. Natl. Acad. Sci. USA 92, 2612-2616.
34. Russell, M. W., Dick, M., Campbell, R. M., Hulse, J. E., Munroe, D. J., Bric, E., Housman, D. E., Collins, F. S., and Brody, L. C. (1995) Localization of Romano-Ward long QT syndrome gene, LQT1, to the interval between tyrosine hydroxylase (TH) and D11S1349 [letter]. Am. J. Hum. Genet. 57, 503-507.
35. Schott, J. J., Charpentier, F., Peltier, S., Foley, P., Drouin, E., Bouhour, J. B., Donnelly, P., Vergnaud, G., Bachner, L., Moisan, J. P., et al. (1995) Mapping of a gene for long QT syndrome to chromosome 4q25-27. Am. J. Hum. Genet. 57, 1114-1122.
36. Levy, R. J., Bolling, S. F., Siden, R., Kadish, A. L., Pathak, Y., Dorostkar, P., Sintov, A., Golomb, G., and Johnston, T. P. (1991) Polymeric controlled release of cardiovascular drug. In Cosmetic and Pharmaceutical Applications of Polymers (Gebelein, C. G., ed.), pp. 231-238, Plenum, New York.